The stocks for both Swiss and Israeli biotechs were up over 20% after the companies signed a merger agreement.

NLS Pharmaceutics (NASDAQ:NLSP) rose in premarket trading on Monday after the company reported a definitive merger agreement with Kadimastem. NLSP (NLSP) stock climbed +57.22% to $5.66 +2.06 premarket ...

NLS Pharmaceutics (NLSP) and Kadimastem announced that they have entered into a definitive merger agreement to combine the ...

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) shares are moving higher on Monday after the company announced it entered into a ...

Left-handers Chris Sale of the Atlanta Braves and Garrett Crochet of the Chicago White Sox were selected Major League ...

NLS Pharmaceutics (NLSP) has released an update. Kadimastem Ltd. faces significant financial challenges as its recent audit reveals recurring losses and a negative cash flow, casting doubt on its ...

NLS is the eighth seed in the Class AA state tournament. They’ll face top-seeded Albany at 1 p.m. Thursday at the Xcel Energy ...

NLS Pharmaceutics (NLSP) has released an update. NLS Pharmaceutics is undertaking a significant restructuring effort by proposing an ordinary ...

ST. PAUL — New London-Spicer was ready for the long haul in the opening round of the Class AA state volleyball quarterfinals.

NLS Pharmaceutics announced it entered into a definitive merger agreement with Kadimastem. One goal of the combined company is to advance NLS's Dual Orexin Agonist platform. NLS Pharmaceutics Ltd ...

NLS Pharma & Kadimastem enter into definitive merger agreement: Zurich, Switzerland Wednesday, November 6, 2024, 12:00 Hrs [IST] NLS Pharmaceutics Ltd. (NLS), a biopharmaceutical ...

ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / November 4, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP) ("NLS"), a biopharmaceutical company, and Kadimastem ...